Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:00837829n
Noun Concept
Categories: Merck brands, Bristol-Myers Squibb, Drugboxes which contain changes to verified fields, Articles without InChI source, Monoclonal antibodies for tumors
EN
cetuximab  Anti EGFR  ATC code L01XC06  ATCvet code QL01XC06  C225
EN
Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer. Wikipedia
Definitions
Relations
Sources
EN
Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer. Wikipedia
Pharmaceutical drug Wikidata
IS A
compound
medicine
monoclonal antibody
biopharmaceutical
MEDICAL CONDITION TREATED
cancroid
Hypopharyngeal cancer
oropharyngeal cancer
laryngeal cancer
non-small-cell lung cancer
+3 relations
PREGNANCY CATEGORY
Australian pregnancy category D
ROUTE OF ADMINISTRATION
intravenous drip
Wikipedia
EN
cetuximab
Wikidata
EN
cetuximab
Wikipedia Redirections
EN
ATC code L01XC06, ATCvet code QL01XC06, C6484H10042N1732O2023S36, Erbitux
Wikidata Alias
EN
Anti EGFR, C225, Erbitux, IMC-225, IMC-C225

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License